SCHEMBL6320615

SCHEMBL6320615

CN(C(=O)OC(C)(C)C)[C@H](Cc1ccccc1F)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.48
CTSK P43235 1/20 0.48
MMP13 P45452 1/20 0.43
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
PTPN1 P18031 1/20 0.42
RIPK1 Q13546 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ATM Q13315 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
AAK1 Q2M2I8 1/20 0.39
SCN9A Q15858 3/20 0.38
GPR119 Q8TDV5 1/20 0.37
CXCL8 P10145 1/20 0.37
SLC1A5 Q15758 1/20 0.36
GAA P10253 1/20 0.36
REN P00797 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25185778 1.00 CTSS (0.48) CTSSCTSKMMP13PPARGPPARA
SCHEMBL17559222 0.87 CTSS (0.48) CTSSCTSKPPARGPPARAPTPN1
SCHEMBL30461876 0.86 RIPK1 (0.43) CTSSCTSKMMP13PTPN1RIPK1
SCHEMBL6317743 0.86 CTSS (0.48) CTSSCTSKMMP13PTPN1RIPK1
SCHEMBL7435174 0.85 MMP13 (0.44) MMP13PPARGPPARAMEN1KMT2A
SCHEMBL25182237 0.85 POLQ (0.49) MMP13PPARGPPARAATMKDM4E
SCHEMBL25270118 0.84 MMP13 (0.46) MMP13PPARGPPARAALDH1A1AAK1
SCHEMBL25179496 0.84 MMP13 (0.46) MMP13PPARGPPARAALDH1A1AAK1
SCHEMBL29079225 0.84 DPP4 (0.44) CTSSCTSKMMP13PTPN1AAK1
SCHEMBL29079221 0.84 DPP4 (0.44) CTSSCTSKMMP13PTPN1AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6939880-B2 Compounds with growth hormone releasing properties NOVO NORDISK A/S (DK) 2005-09-06 US disclosed
US-6555570-B2 Growth hormone secretagogous with improved bioavailability NOVO NORDISK A/S (DE) 2003-04-29 US disclosed
US-20030055261-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-03-20 US disclosed
US-20030040483-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-02-27 US disclosed
US-6127391-A A PEPTIDE MIMETIC COMPOUND FOR STIMULATING THE RELEASE OF GROWTH HORMONE FROM THE PITUITARY NOVO NORDISK A/S (DK) 2000-10-03 US disclosed
US-5977178-A Compounds with growth hormone releasing properties NOVO NORDISK A/S (DK) 1999-11-02 US disclosed
CN-1211991-A Compounds with growth hormone releasing properties NOVO NORDISK AS (DK) 1999-03-24 CN disclosed
EP-0869974-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1998-10-14 EP disclosed
WO-1997023508-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055261-A1 Compounds with growth hormone releasing properties GHRHR, GHSR, IGFBP1 CTSS 2319/4885CTSK 1324/4885MMP13 2217/4885
US-20030040483-A1 Compounds with growth hormone releasing properties GHRHR, GHSR, GRPR CTSS 2636/4885CTSK 1778/4885MMP13 2288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.